Product Program year 2025 Source: CMS Open Payments

Aveir

Device Cardiac Rhythm Management

PDI 05415067034847

Open in the dashboard

General payments

$3,984,861

28,284 payments

Research payments

$4,545,995

1,000 payments

Through program year 2025, $3,984,861 in general payments and $4,545,995 in research payments were reported against Aveir (Cardiac Rhythm Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 Research $91,355 13
2024 General $1,883,343 13,908
2024 Research $180,532 98
2023 General $2,101,418 14,375
2023 Research $4,274,108 889
2022 General $99 1

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $3,984,861 28,284 payments
Top recipients General payments · program year 2024
  1. Cyrus Hadadi Cardiovascular Disease · Norfolk, VA $88,184 5% · 81 payments
  2. Devi Nair Clinical Cardiac Electrophysiology · Jonesboro, AR $75,157 4% · 81 payments
  3. Raul Weiss Clinical Cardiac Electrophysiology · Miami Beach, FL $65,896 3% · 11 payments
  4. James Ip Clinical Cardiac Electrophysiology · New York, NY $46,991 2% · 44 payments
  5. Rahul Doshi Clinical Cardiac Electrophysiology · Los Angeles, CA $37,617 2% · 46 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Clinical Cardiac Electrophysiology Internal Medicine $1,256,107 68% · 1,168 practitioners
  2. Cardiovascular Disease Internal Medicine $357,863 19% · 787 practitioners
  3. Interventional Cardiology Internal Medicine $79,592 4% · 378 practitioners
  4. Internal Medicine $31,046 2% · 153 practitioners
  5. Pediatric Cardiology Pediatrics $20,560 1% · 19 practitioners

The top 5 of 95 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $235,122 12% · 417 recipients
  2. Florida $220,721 12% · 451 recipients
  3. Texas $163,716 9% · 392 recipients
  4. New York $158,998 8% · 231 recipients
  5. Virginia $113,106 6% · 42 recipients

The top 5 of 51 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

28,284 general · 1,000 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record